Posted in | News | Nanobusiness

NanoString Technologies Launches the Early Access Program for the nCounter Analysis System for Digital Gene Expression

NanoString Technologies today announced the launch of the Early Access Program for the nCounter Analysis System for digital gene expression. NanoString has shipped a system to the first Early Access customer, Professor Eric Davidson, at the California Institute for Technology and has begun accepting orders from other customers.

The nCounter Analysis System uses a novel digital technology that is based on direct multiplexed measurement of gene expression and offers high levels of sensitivity (500 attomolar) and precision. The technology uses molecular barcodes and single molecule imaging to detect and count hundreds of unique transcripts in a single reaction. The fully automated system is easy to use and is ideally suited for researchers with small amounts of starting material, customers who would like to study defined gene sets and microarray users seeking to validate expression signatures.

“The nCounter Analysis System offers an unprecedented combination of sensitivity, precision and datapoint throughput for gene expression analysis. The real benefit for researchers is that they can effectively interrogate more genes across more samples, cost effectively and in less time than conventional methods,” said Alan Dance, Chief Commercial Officer at NanoString Technologies. “We are delighted that such a prominent researcher as Dr. Davidson will be our first customer.”

“We have carried out extensive head-to-head comparisons between the nCounter System and Quantitative PCR on the same samples over the last year, and nCounter has the distinct advantage that more data can be obtained in less time, on less starting material, without at all compromising data quality,” said Dr. Eric Davidson, Professor of Cell Biology at California Institute of Technology. “Highly sensitive and accurate analysis of gene expression is the fundamental data acquisition step in our developmental biology research on gene regulatory networks.”

The nCounter Analysis System is comprised of a fully automated prep station, a digital analyzer, the CodeSet (barcodes) and all of the reagents and consumables needed to perform the analysis. The CodeSets can currently assay up to 576 gene targets per reaction, and that number is expected to increase in the next few months. The system has been designed to be easy to use and features a step-by-step guide to perform the analysis on a touch screen.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Nanostring Technologies. (2019, February 15). NanoString Technologies Launches the Early Access Program for the nCounter Analysis System for Digital Gene Expression. AZoNano. Retrieved on February 29, 2024 from https://www.azonano.com/news.aspx?newsID=5506.

  • MLA

    Nanostring Technologies. "NanoString Technologies Launches the Early Access Program for the nCounter Analysis System for Digital Gene Expression". AZoNano. 29 February 2024. <https://www.azonano.com/news.aspx?newsID=5506>.

  • Chicago

    Nanostring Technologies. "NanoString Technologies Launches the Early Access Program for the nCounter Analysis System for Digital Gene Expression". AZoNano. https://www.azonano.com/news.aspx?newsID=5506. (accessed February 29, 2024).

  • Harvard

    Nanostring Technologies. 2019. NanoString Technologies Launches the Early Access Program for the nCounter Analysis System for Digital Gene Expression. AZoNano, viewed 29 February 2024, https://www.azonano.com/news.aspx?newsID=5506.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit
Azthena logo

AZoM.com powered by Azthena AI

Your AI Assistant finding answers from trusted AZoM content

Your AI Powered Scientific Assistant

Hi, I'm Azthena, you can trust me to find commercial scientific answers from AZoNetwork.com.

A few things you need to know before we start. Please read and accept to continue.

  • Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
  • Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
  • Large Language Models can make mistakes. Consider checking important information.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.